Baseline Characteristics and Interim Month 12 mNAPSI Results in Patients with Moderate-to- Severe Plaque Psoriasis and Concomitant Nail Psoriasis Treated with Biologics in the Psoriasis Study of Health Outcomes (PSoHO)

被引：0
|
作者：
Egeberg, Alexander [1 ]
Pinter, Andreas [2 ]
Vender, Ronald [3 ]
Zaheri, Shirin [4 ]
Brnabic, Alan [5 ]
Schuster, Christopher [5 ,6 ]
Elrayes, Mohamed [5 ]
Reed, Catherine [5 ]
Riedl, Elisabeth [6 ]
Puig, Luis [7 ]
机构：
[1] Copenhagen Univ Hosp, Dept Dermatol, Copenhagen, Denmark
[2] Univ Hosp Frankfurt, Clin Dermatol Venereol & Allergol, Frankfurt, Germany
[3] Dermatrials Res Inc, Hamilton, ON, Canada
[4] HCA Healthcare, London, England
[5] Eli Lilly & Co, Indianapolis, IN USA
[6] Med Univ Vienna, Dept Dermatol, Vienna, Austria
[7] Univ Autonoma Barcelona, Dept Dermatol, IIB SANT PAU, Hosp Santa Creu & Sant Pau, Barcelona, Spain
来源：
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY | 2023年 / 89卷 / 03期
关键词：
D O I：
暂无
中图分类号：
R75 [皮肤病学与性病学];
学科分类号：
100206 ;
摘要：
42592
引用
下载
收藏
页码：AB127 / AB127
页数：1
相关论文
共 50 条
  • [41] Moderate-to-severe plaque psoriasis patients treated with ixekizumab: early real-world outcomes and adverse events
    Gulliver, Wayne
    Penney, Michelle
    Power, Rebecca
    Gulliver, Susanne
    Montmayeur, Sonia
    Burge, Russel
    JOURNAL OF DERMATOLOGICAL TREATMENT, 2022, 33 (01) : 354 - 360
  • [42] Effectiveness and Safety of Secukinumab in Latin American Patients with Moderate to Severe Plaque Psoriasis: PURE Registry 12-Month Data
    Papp, Kim A.
    Gooderham, Melinda
    Dei-Cas, Ignacio
    LopezTello, Adriana
    Garcia-Rodriguez, Juan C.
    Taveras, Carmen Yris
    Rousselin, Azucena Hernandez
    Lavieri, Alberto
    Maiolino, Monica
    Villanueva Quintero, Delfina Guadalupe
    Rihakova, Lenka
    Salibe, Mariano
    Pertuz, Wilfran
    DERMATOLOGY AND THERAPY, 2023, 13 (01) : 269 - 283
  • [43] Effectiveness and Safety of Secukinumab in Latin American Patients with Moderate to Severe Plaque Psoriasis: PURE Registry 12-Month Data
    Papp, Kim A.
    Gooderham, Melinda
    Dei-Cas, Ignacio
    LopezTello, Adriana
    Garcia-Rodriguez, Juan C.
    Taveras, Carmen Yris
    Rousselin, Azucena Hernandez
    Lavieri, Alberto
    Maiolino, Monica
    Quintero, Delfina Guadalupe Villanueva
    Rihakova, Lenka
    Salibe, Mariano
    Pertuz, Wilfran
    DERMATOLOGY AND THERAPY, 2022,
  • [44] Effectiveness and Safety of Secukinumab in Latin American Patients with Moderate to Severe Plaque Psoriasis: PURE Registry 12-Month Data
    Kim A. Papp
    Melinda Gooderham
    Ignacio Dei-Cas
    Adriana LopezTello
    Juan C. Garcia-Rodriguez
    Carmen Yris Taveras
    Azucena Hernández Rousselin
    Alberto Lavieri
    Mónica Maiolino
    Delfina Guadalupe Villanueva Quintero
    Lenka Rihakova
    Mariano Salibe
    Wilfran Pertuz
    Dermatology and Therapy, 2023, 13 : 269 - 283
  • [45] Comparison of patient reported outcomes by biologic treatment use in patients with moderate to severe plaque psoriasis: Results from a compiled dataset of National Psoriasis Foundation panel surveys
    Edson-Heredia, Emily
    Zhu, Baojin
    Guo, Jiaying
    Lebwohl, Mark
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2013, 68 (04) : AB195 - AB195
  • [46] Treatment with secukinumab of severe plaque psoriasis in pediatric patients: Study design and baseline characteristics of a double-blind study
    Kaszuba, Andrzej
    Papanastasiou, Philemon
    Keefe, Deborah
    Patekar, Manmath
    Zhang, Lixin
    Wraith, Linda Ann
    Tsianakas, A.
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2020, 83 (06) : AB133 - AB133
  • [47] REAL WORLD SKIN CLEARANCE RATES FOR BIOLOGIC TREATMENTS IN PATIENTS WITH MODERATE TO SEVERE PLAQUE PSORIASIS: INTERIM RESULTS FROM A LARGE PROSPECTIVE, OBSERVATIONAL STUDY
    Paul, C.
    Bewley, A.
    Girolomoni, G.
    Reich, K.
    Puig, L.
    Lacour, J. P.
    Augustin, M.
    Naldi, L.
    Menter, A. M.
    Wade, S.
    Viswanathan, H. N.
    Palmer, K.
    Klekotka, P.
    Woolley, J. M.
    VALUE IN HEALTH, 2015, 18 (07) : A429 - A429
  • [48] Real world experience of brodalumab treatment in patients with moderate-to-severe plaque psoriasis in the Greek population: Results from an interim analysis of the BrIDGE study
    Rigopoulos, Dimitrios
    Angelakopoulos, Charalampos
    Apalla, Zoi
    Georgiou, Sophia
    Delli, Florentina
    Drosos, Alexandros
    Zafiriou, Efterpi
    Katsantonis, John
    Lazaridou, Elisavet
    Panagakis, Pantelis
    Papadavid, Evangelia
    Papakonstantis, Markos
    Roussaki-Schulze, Angeliki-Viktoria
    Sotiriou, Elena
    Anastasiadis, Georgios
    Tampouratzi, Eleftheria
    Chasapi, Vasiliki
    Sfaelos, Konstantinos
    Ioannides, Dimitrios
    DERMATOLOGIC THERAPY, 2022, 35 (12)
  • [49] Unmet needs in patients with moderate-to-severe plaque psoriasis treated with methotrexate in real world practice: FirST study
    Rivera, Raquel
    Vilarrasa, E.
    Ribera, M.
    Roe, E.
    Kueder-Pajares, T.
    Zayas, A. I.
    Martinez-Molina, L.
    Mataix Diaz, J.
    Rodriguez-Nevado, I. M.
    Usero-Barcena, T.
    de la Mano, D.
    Garcia-Donoso, C.
    Olveira, A.
    Guinea, G.
    Martin-Vazquez, V.
    Ferran, M.
    JOURNAL OF DERMATOLOGICAL TREATMENT, 2022, 33 (03) : 1329 - 1338
  • [50] Improvements in Psoriasis-Related Work Productivity with Tildrakizumab: Results from a Phase 4 Real-World Study in Patients with Moderate-to-Severe Plaque Psoriasis
    Tina Bhutani
    John Koo
    Jayme Heim
    Neal Bhatia
    Jacob Mathew
    Thomas Ferro
    J. Gabriel Vasquez
    Dermatology and Therapy, 2024, 14 : 1019 - 1025
12345